Management of Cardiac Toxicity Induced by Chemotherapy.
Ontology highlight
ABSTRACT: Cardiotoxicity encompasses a spectrum of adverse cardiological effects experienced by cancer patients during and after receiving antineoplastic treatments. The intersection of cancer care with the management of the multiple comorbid non-communicable diseases carried by patients or related to cancer treatments motivates the need for an integrated and multidisciplinary approach to therapeutic clinical decision-making. This present review aimed to provide a perspective and an update of the current pharmacotherapy approaches for the prevention and management of cardiotoxicity from antiblastic chemotherapy; as such, it addresses myocardial, vascular, and arrhythmic disorders associated to chemotherapy, by navigating the current knowledge and clinical indications in support of the medical interv
SUBMITTER: Trapani D
PROVIDER: S-EPMC7565686 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA